Research indicates that GLP-1 medications, such as Ozempic, may elevate the risk of developing a rare eye condition that can lead to vision loss. This potential side effect is significant for patients using these drugs for weight management or diabetes treatment.
Routine eye examinations could be beneficial for individuals on GLP-1 medications to monitor any changes in vision and address potential issues early on.
Patients using GLP-1 medications like Ozempic should prioritize regular eye check-ups to catch any vision changes early. Healthcare providers may need to discuss the risk of this rare eye condition with patients, ensuring informed decisions about treatment options.